Skip to main content
. 2019 May 11;11(5):229. doi: 10.3390/pharmaceutics11050229

Table 1.

Experimental and control groups of immunized mice. Mice were immunized intradermally (ID) at day 0 and 21 with the indicated dose at a volume of 50 µL/injection and terminated at day 35.

Group Dose GI.4 + GII.4 Dose VP6 Mice/Group
I 0.3 µg + 0.3 µg - 5
II 0.3 µg + 0.3 µg 10 µg 5
III 1 µg + 1 µg - 5
IV 1 µg + 1 µg 1 µg 5
V (Control) - 1 - 5

1 phosphate buffered saline (PBS), carrier only.